TRIM42
gene geneOn this page
Also known as FLJ40097PPP1R40T4A1
Summary
TRIM42 (tripartite motif containing 42, HGNC:19014) is a protein-coding gene on chromosome 3q23, encoding Tripartite motif-containing protein 42 (Q8IWZ5).
This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, namely a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region.
Source: NCBI Gene 287015 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 112 total
- MANE Select transcript:
NM_152616
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19014 |
| Approved symbol | TRIM42 |
| Name | tripartite motif containing 42 |
| Location | 3q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40097, PPP1R40, T4A1 |
| Ensembl gene | ENSG00000155890 |
| Ensembl biotype | protein_coding |
| OMIM | 620334 |
| Entrez | 287015 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000286349
RefSeq mRNA: 1 — MANE Select: NM_152616
NM_152616
CCDS: CCDS3113
Canonical transcript exons
ENST00000286349 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001023275 | 140682462 | 140683159 |
| ENSE00001023277 | 140687722 | 140688542 |
| ENSE00001077543 | 140678064 | 140678570 |
| ENSE00001136757 | 140690968 | 140691192 |
| ENSE00001246699 | 140700888 | 140701150 |
Expression profiles
Bgee: expression breadth broad, 15 present calls, max score 83.68.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0853 / max 78.0377, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 38856 | 0.0804 | 4 |
| 38855 | 0.0049 | 3 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.68 | gold quality |
| left testis | UBERON:0004533 | 79.41 | gold quality |
| right testis | UBERON:0004534 | 77.97 | gold quality |
| testis | UBERON:0000473 | 77.05 | gold quality |
| secondary oocyte | CL:0000655 | 63.03 | gold quality |
| cerebellar vermis | UBERON:0004720 | 58.21 | gold quality |
| adult organism | UBERON:0007023 | 55.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 52.15 | gold quality |
| oocyte | CL:0000023 | 48.25 | gold quality |
| thymus | UBERON:0002370 | 43.37 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| quadriceps femoris | UBERON:0001377 | 43.34 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 41.97 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| sperm | CL:0000019 | 40.97 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting TRIM42, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-934 | 98.49 | 70.44 | 581 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Trim42 | ENSMUSG00000032451 |
| rattus_norvegicus | Trim42 | ENSRNOG00000048975 |
Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM63 (ENSG00000158022)
Protein
Protein identifiers
Tripartite motif-containing protein 42 — Q8IWZ5 (reviewed: Q8IWZ5)
All UniProt accessions (1): Q8IWZ5
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the TRIM/RBCC family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IWZ5-1 | 1 | yes |
| Q8IWZ5-2 | 2 |
RefSeq proteins (1): NP_689829* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000315 | Znf_B-box | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR003961 | FN3_dom | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR017903 | COS_domain | Domain |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR036116 | FN3_sf | Homologous_superfamily |
| IPR042765 | TRIM42_RING-HC | Domain |
| IPR051051 | E3_ubiq-ligase_TRIM/RNF | Family |
Pfam: PF00041, PF00643
UniProt features (17 total): binding site 4, sequence variant 3, zinc finger region 3, domain 2, splice variant 2, chain 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IWZ5-F1 | 65.42 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 318; 290; 293; 313
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, CHENG_IMPRINTED_BY_ESTRADIOL, MIR6867_5P, MIR4261, MIR147B_5P, MIR934, GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION, chr3q23, RTAAACA_FREAC2_01, GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP
GO Biological Process (1): protein ubiquitination (GO:0016567)
GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIM42 | C10orf120 | Q5SQS8 | 571 |
| TRIM42 | C5orf47 | Q569G3 | 539 |
| TRIM42 | TRIM27 | P14373 | 537 |
| TRIM42 | TRIM77 | I1YAP6 | 502 |
| TRIM42 | ZPLD1 | Q8TCW7 | 487 |
| TRIM42 | TRIM47 | Q96LD4 | 480 |
| TRIM42 | CCDC27 | Q2M243 | 477 |
| TRIM42 | TRIM69 | Q86WT6 | 476 |
| TRIM42 | TGIF2LX | Q8IUE1 | 476 |
| TRIM42 | TRIM41 | Q8WV44 | 472 |
| TRIM42 | SAXO1 | Q8IYX7 | 468 |
| TRIM42 | TRIM23 | P36406 | 461 |
| TRIM42 | TRIM64 | A6NGJ6 | 460 |
| TRIM42 | TRIM4 | Q9C037 | 457 |
| TRIM42 | SPRED3 | Q2MJR0 | 454 |
IntAct
513 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM42 | HOXA1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM42 | LONRF1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KCTD9 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM42 | STK16 | psi-mi:“MI:0915”(physical association) | 0.720 |
| EMD | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LONRF1 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM42 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM42 | KCTD9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| HOXA1 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM42 | YWHAQ | psi-mi:“MI:0915”(physical association) | 0.670 |
| YWHAQ | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KRT13 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM42 | GLI1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM27 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM42 | KRT15 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (158): TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid), TRIM42 (Two-hybrid)
ESM2 similar proteins: A0A7H0DN99, A0A8V8TMC4, D3YUJ3, I2HAA0, O01501, O13818, O14260, O14332, O17657, O42575, O43008, P06776, P0C7X3, P17214, P25009, P30645, P34624, P36034, P38729, P52924, P53053, P53124, Q03080, Q05930, Q07788, Q08C99, Q08CI4, Q09792, Q10326, Q10PQ9, Q22695, Q28EL0, Q4R871, Q5IBH7, Q5ICL9, Q5MJ70, Q5T2Q4, Q5U5D0, Q6NRF4, Q75D04
Diamond homologs: G4SLH0, Q6NWW9, Q8IWZ5, Q9D2H5, O95361, Q5R760
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | TRIM42 | ubiquitination |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 59 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 8 | 13.5× | 2e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
112 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 103 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1113 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:140678571:G:GG | donor_gain | 1.0000 |
| 3:140687720:A:AG | acceptor_gain | 1.0000 |
| 3:140687721:G:GG | acceptor_gain | 1.0000 |
| 3:140690962:CCATA:C | acceptor_loss | 1.0000 |
| 3:140690963:CATA:C | acceptor_loss | 1.0000 |
| 3:140690966:A:AC | acceptor_loss | 1.0000 |
| 3:140690967:G:GT | acceptor_loss | 1.0000 |
| 3:140678568:CTC:C | donor_gain | 0.9900 |
| 3:140682460:A:AG | acceptor_gain | 0.9900 |
| 3:140682461:G:GA | acceptor_gain | 0.9900 |
| 3:140683150:TTCA:T | donor_gain | 0.9900 |
| 3:140690688:C:CA | acceptor_gain | 0.9900 |
| 3:140690966:A:AG | acceptor_gain | 0.9900 |
| 3:140690967:G:GG | acceptor_gain | 0.9900 |
| 3:140691127:GAA:G | donor_gain | 0.9900 |
| 3:140691129:A:AG | donor_gain | 0.9900 |
| 3:140691141:A:AG | donor_gain | 0.9900 |
| 3:140691142:G:GG | donor_gain | 0.9900 |
| 3:140691189:CAAG:C | donor_loss | 0.9900 |
| 3:140691190:AAG:A | donor_loss | 0.9900 |
| 3:140691191:AG:A | donor_loss | 0.9900 |
| 3:140691192:G:GT | donor_loss | 0.9900 |
| 3:140700882:TTGCA:T | acceptor_loss | 0.9900 |
| 3:140700883:TGCAG:T | acceptor_loss | 0.9900 |
| 3:140700884:GCAG:G | acceptor_loss | 0.9900 |
| 3:140700885:CAGG:C | acceptor_loss | 0.9900 |
| 3:140700886:A:G | acceptor_loss | 0.9900 |
| 3:140700886:AGGT:A | acceptor_gain | 0.9900 |
| 3:140700887:G:GA | acceptor_loss | 0.9900 |
| 3:140700887:GGTG:G | acceptor_gain | 0.9900 |
AlphaMissense
4861 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:140682682:T:C | C188R | 0.999 |
| 3:140682988:T:C | C290R | 0.999 |
| 3:140690974:T:A | W623R | 0.999 |
| 3:140690974:T:C | W623R | 0.999 |
| 3:140682684:C:G | C188W | 0.998 |
| 3:140682691:T:C | C191R | 0.998 |
| 3:140682832:T:C | C238R | 0.998 |
| 3:140683048:T:C | C310R | 0.998 |
| 3:140683050:C:G | C310W | 0.998 |
| 3:140687979:G:C | A433P | 0.998 |
| 3:140688006:T:C | F442L | 0.998 |
| 3:140688008:C:A | F442L | 0.998 |
| 3:140688008:C:G | F442L | 0.998 |
| 3:140688010:T:C | L443P | 0.998 |
| 3:140688018:G:C | A446P | 0.998 |
| 3:140691175:T:A | W690R | 0.998 |
| 3:140691175:T:C | W690R | 0.998 |
| 3:140682556:T:C | C146R | 0.997 |
| 3:140682601:T:C | C161R | 0.997 |
| 3:140682602:G:A | C161Y | 0.997 |
| 3:140682603:C:G | C161W | 0.997 |
| 3:140682616:T:C | C166R | 0.997 |
| 3:140682683:G:A | C188Y | 0.997 |
| 3:140682691:T:A | C191S | 0.997 |
| 3:140682692:G:A | C191Y | 0.997 |
| 3:140682692:G:C | C191S | 0.997 |
| 3:140682693:C:G | C191W | 0.997 |
| 3:140682832:T:A | C238S | 0.997 |
| 3:140682833:G:C | C238S | 0.997 |
| 3:140682860:C:A | A247D | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000153426 (3:140678929 G>A), RS1000432369 (3:140690140 T>C), RS1000615070 (3:140683414 G>C), RS1000670243 (3:140676717 A>G), RS1001056448 (3:140697070 C>T), RS1001217007 (3:140678168 C>A,T), RS1001699552 (3:140684881 T>C), RS1001716890 (3:140696758 A>G), RS1001717941 (3:140677618 A>G), RS1001928772 (3:140684260 G>A,T), RS1001935571 (3:140690053 C>T), RS1002017110 (3:140698280 G>A), RS1002178234 (3:140697417 G>A), RS1002186837 (3:140676278 T>C), RS1002403668 (3:140684582 AC>A)
Disease associations
OMIM: gene MIM:620334 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002306_50 | Bipolar disorder (body mass index interaction) | 7.000000e-09 |
| GCST002685_7 | Refractive astigmatism | 5.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctanoic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.